ENG

EST
RUS

Icosagen

COVID-19
Services
Products
IcoCell
Technologies and R&D
- QMCF Technology & licensing
- EU projects/R&D collaboration
Quality Control Services
- Food microbiology testing services
- Latex allergen testing with FITkit
Contact us
- History
- About us
- Management
- Our team
News

Close menu

Menu

News

News

July 31, 2017

Meet us at AACC 2017 in San Diego

Come and join us for a scientific discussion in booth 5359 at AACC meeting in San Diego.

‹ Back to news

Latest news

Happy holidays
December 24, 2020
Estonian Biotech Icosagen Has Developed Highly Potent Next-Generation Therapeutic and Preventative Anti-SARS-CoV-2 Neutralizing Antibodies as Promising Drug Candidates for Covid-19
October 21, 2020

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108
+1 415 548 6625

Contact US Office

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070

Contact EU Office

Recombinant antibody production
Antibody development
Protein production
Expression of membrane proteins

Antibodies
Proteins
ELISA kits
Transfection reagent
Local distributors

Technologies and R&D

QMCF Technology & licensing
EU projects/R&D collaboration

Quality Control Services

Food microbiology testing services
Latex allergen testing with FITkit

History
About us
Management
Our team

Back to top

Icosagen